|
ZNF234 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.06869999999737E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.33480004826936E-09 |
| Normal-vs-Stage2 |
1.851740E-02 |
| Normal-vs-Stage3 |
1.469020E-01 |
| Normal-vs-Stage4 |
5.529200E-01 |
| Stage1-vs-Stage2 |
2.790600E-01 |
| Stage1-vs-Stage3 |
1.577060E-04 |
| Stage1-vs-Stage4 |
6.48340000000136E-05 |
| Stage2-vs-Stage3 |
1.596620E-01 |
| Stage2-vs-Stage4 |
6.844400E-02 |
| Stage3-vs-Stage4 |
5.037800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.55396999999002E-05 |
| Normal-vs-AfricanAmerican |
6.135900E-02 |
| Normal-vs-Asian |
1.030560E-01 |
| Caucasian-vs-AfricanAmerican |
6.002800E-01 |
| Caucasian-vs-Asian |
1.789820E-01 |
| AfricanAmerican-vs-Asian |
1.754580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.035100E-04 |
| Normal-vs-Female |
2.46199999998087E-06 |
| Male-vs-Female |
1.374170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.993600E-02 |
| Normal-vs-Age(41-60Yrs) |
3.47419999990883E-07 |
| Normal-vs-Age(61-80Yrs) |
1.979910E-03 |
| Normal-vs-Age(81-100Yrs) |
4.404800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.245000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.166400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.920800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.226500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.586210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.650200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.402300E-04 |
| Normal-vs-Grade 2 |
5.65919999750975E-09 |
| Normal-vs-Grade 3 |
6.259500E-03 |
| Normal-vs-Grade 4 |
7.136800E-01 |
| Grade 1-vs-Grade 2 |
3.285900E-02 |
| Grade 1-vs-Grade 3 |
3.173800E-04 |
| Grade 1-vs-Grade 4 |
7.18460000048715E-07 |
| Grade 2-vs-Grade 3 |
1.118910E-03 |
| Grade 2-vs-Grade 4 |
1.92420000044713E-07 |
| Grade 3-vs-Grade 4 |
1.427580E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.09209974397118E-10 |
| Normal-vs-ccB subtype |
4.021900E-02 |
| ccA subtype-vs-ccB subtype |
2.01619999999902E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.432430E-04 |
| Normal-vs-N1 |
6.931800E-01 |
| N0-vs-N1 |
8.352500E-02 |
|
|
